Improved antifungal activity of itraconazole-loaded PEG/PLA nanoparticles

References

• Akkar A, Müller RH. Intravenous itraconazole emulsions produced by SolEmuls technology. Eur J Pharm Biopharm 2003; 56: 29–36
   PubMed Web of Science ®Google Scholar
• Beletsi A, Panagi Z, Avgoustakis K. Biodistribution properties of nanoparticles based on mixtures of PLGA with PLGA–PEG diblock copolymers. Int J Pharm 2005; 298: 233–41
   PubMed Web of Science ®Google Scholar
• Beyth N, Houri-Haddad Y, Baraness-Hadar L, Yudovin-Farber I, Domb AJ, Weiss EI. Surface antimicrobial activity and biocompatibility of incorporated polyethylenimine nanoparticles. Biomaterials 2008; 29: 4157–63
   PubMed Web of Science ®Google Scholar
• Boogaerts M, Maertens J. Clinical experience with Itraconazole in systemic fungal infections. Drugs 2001; 61: 39–47
   PubMed Web of Science ®Google Scholar
• Bouillot P, Babak V, Dellacherie E. Novel bioresorbable and bioeliminable surfactants for microsphere preparation. Pharm Res 1999; 16: 148–54
   PubMed Web of Science ®Google Scholar
• Brewer E, Coleman J, Lowman A. Emerging technologies of polymeric nanoparticles in cancer drug delivery. J Nanomater 2011; 2011: 1–10
   PubMed Web of Science ®Google Scholar
• Cha E-J, Kim JE, Ahn C-H. Stabilized polymeric micelles by electrostatic interactions for drug delivery system. Eur J Pharm Sci 2009; 38: 341–6
   PubMed Web of Science ®Google Scholar
• Chen W, Gu B, Wang H, Pan J, Lu W, Hou H. Development and evaluation of novel itraconazole-loaded intravenous nanoparticles. Int J Pharm 2008; 362: 133–40
   PubMed Web of Science ®Google Scholar
• Chen J, Tian B, Yin X, Zhang Y, Hu D, Hu Z, Liu M, Pan Y, Zhao J, Li H, et al. Preparation, characterization and transfection efficiency of cationic PEGylated PLA nanoparticles as gene delivery systems. J Biotechnol 2007; 130: 107–13
   PubMed Web of Science ®Google Scholar
• Cohen BE. Amphotericin B toxicity and lethality: A tale of two channels. Int J Pharm 1998; 162: 95–106
   Web of Science ®Google Scholar
• De Beule K. Itraconazole: Pharmacology, clinical experience and future development. Int J Antimicrob Agents 1996; 6: 175–81
   PubMed Web of Science ®Google Scholar
• Dong Y, Feng S-S. Methoxy poly(ethylene glycol)-poly(lactide) (MPEG–PLA) nanoparticles for controlled delivery of anticancer drugs. Biomaterials 2004; 25: 2843–9
   PubMed Web of Science ®Google Scholar
• Essa S, Rabanel JM, Hildgen P. Effect of polyethylene glycol (PEG) chain organization on the physicochemical properties of poly(D,L-lactide) (PLA) based nanoparticles. Eur J Pharm Biopharm 2010a; 75: 96–106
   PubMed Web of Science ®Google Scholar
• Essa S, Rabanel JM, Hildgen P. Effect of aqueous solubility of grafted moiety on the physicochemical properties of poly(D,L-lactide) (PLA) based nanoparticles. Int J Pharm 2010b; 388: 263–73
   PubMedGoogle Scholar
• Gref R, Lück M, Quellec P, Marchand M, Dellacherie E, Harnisch S, Blunk T, Müller RH. ‘Stealth’ corona-core nanoparticles surface modified by polyethylene glycol (PEG): Influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption. Colloids Surf B 2000; 18: 301–13
   PubMed Web of Science ®Google Scholar
• Horn R, Wong B, Kiehn TE, Armstrong D. Fungemia in a cancer hospital: Changing frequency, earlier onset, and results of therapy. Rev Infect Dis 1985; 7: 646–55
   PubMedGoogle Scholar
• Isoherranen N, Kunze KL, Allen KE, Nelson WL, Thummel KE. Role of itraconazole metabolites in CYP3A4 inhibition. Drug Metab Dispos 2004; 32: 1121–31
   PubMed Web of Science ®Google Scholar
• Italia J, Yahya M, Singh D, Ravi Kumar M. Biodegradable nanoparticles improve oral bioavailability of Amphotericin B and show reduced nephrotoxicity compared to intravenous Fungizone®. Pharm Res 2009; 26: 1324–31
   PubMed Web of Science ®Google Scholar
• Kallinteri P, Garnett MC. Polymeric nanoparticles for drug delivery. Nanotechnologies for the life sciences, CSSR Kumar. Wiley-VCH Verlag GmbH & Co KGaA, Weinheim 2007
   Google Scholar
• Kim J-K, Park J-S, Kim C-K. Development of a binary lipid nanoparticles formulation of itraconazole for parenteral administration and controlled release. Int J Pharm 2010; 383(1–2)209–15
   PubMed Web of Science ®Google Scholar
• Koks CHW, Meenhorst PL, Bult A, Beijnen JH. Itraconazole solution: Summary of pharmacokinetic features and review of activity in the treatment of fluconazole-resistant oral candidosis in HIV-infected persons. Pharmacol Res 2002; 46: 195–201
   PubMed Web of Science ®Google Scholar
• Li J, Xiao H, Li J, Zhong Y. Drug carrier systems based on water-soluble cationic [beta]-cyclodextrin polymers. Int J Pharm 2004; 278: 329–42
   PubMed Web of Science ®Google Scholar
• Liu M, Dong J, Yang Y, Yang X, Xu H. Characterization and release of triptolide-loaded poly (D,L-lactic acid) nanoparticles. Eur Polym J 2005; 41: 375–82
   Web of Science ®Google Scholar
• Magenheim B, Levy MY, Benita S. A new in-vitro technique for the evaluation of drug-release profile from colloidal carriers – ultrafiltration technique at low-pressure. Int J Pharm 1993; 94: 115–23
   Web of Science ®Google Scholar
• Mittal G, Sahana DK, Bhardwaj V, Ravi Kumar MNV. Estradiol loaded PLGA nanoparticles for oral administration: Effect of polymer molecular weight and copolymer composition on release behavior in vitro and in vivo. J Control Release 2007; 119: 77–85
   PubMed Web of Science ®Google Scholar
• Muranaka M, Hirota K, Ono T. PEG–PLA nanoparticles prepared by emulsion solvent diffusion using oil-soluble and water-soluble PEG–PLA. Mater Lett 2010; 64: 969–71
   Web of Science ®Google Scholar
• Nadeau V, Leclair G, Sant S, Rabanel J-M, Quesnel R, Hildgen P. Synthesis of new versatile functionalized polyesters for biomedical applications. Polymer 2005; 46: 11263–72
   Web of Science ®Google Scholar
• Pandey R, Ahmad Z, Sharma S, Khuller GK. Nano-encapsulation of azole antifungals: Potential applications to improve oral drug delivery. Int J Pharm 2005; 301: 268–76
   PubMed Web of Science ®Google Scholar
• Panyam J, Dali MM, Sahoo SK, Ma W, Chakravarthi SS, Amidon GL, Levy RJ, Labhasetwar V. Polymer degradation and in vitro release of a model protein from poly(D,L-lactide-co-glycolide) nano- and micro-particles. J Control Release 2003; 92: 173–87
   PubMed Web of Science ®Google Scholar
• Panyam J, Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev 2003; 55: 329–47
   PubMed Web of Science ®Google Scholar
• Panyam J, Williams D, Dash A, Leslie-Pelecky D, Labhasetwar V. Solid-state solubility influences encapsulation and release of hydrophobic drugs from PLGA/PLA nanoparticles. J Pharm Sci 2004; 93: 1804–14
   PubMed Web of Science ®Google Scholar
• PDR T. Physician's desk reference59th edn. Thomson PDR, Montvale, NJ 2005
   Google Scholar
• Peeters J, Neeskens P, Tollenaere JP, van Remoortere P, Brewster ME. Characterization of the interaction of 2-hydroxypropyl-β-cyclodextrin with itraconazole at pH 2, 4, and 7. J Pharm Sci 2002; 91: 1414–22
   PubMed Web of Science ®Google Scholar
• Peng H-S, Liu X-J, Lv G-X, Sun B, Kong Q-F, Zhai D-X, Wang Q, Zhao W, Wang G-Y, Wang D-D, et al. Voriconazole into PLGA nanoparticles: Improving agglomeration and antifungal efficacy. Int J Pharm 2008; 352: 29–35
   PubMed Web of Science ®Google Scholar
• Peracchia MT, Gref R, Minamitake Y, Domb A, Lotan N, Langer R. PEG-coated nanospheres from amphiphilic diblock and multiblock copolymers: Investigation of their drug encapsulation and release characteristics. J Control Release 1997; 46: 223–31
   Web of Science ®Google Scholar
• Quesnel R, Hildgen P. Synthesis of PLA-b-PEG multiblock copolymers for stealth drug carrier preparation. Molecules 2005; 10: 98–104
   PubMed Web of Science ®Google Scholar
• Rabinow B, Kipp J, Papadopoulos P, Wong J, Glosson J, Gass J, Sun C-S, Wielgos T, White R, Cook C, et al. Itraconazole IV nanosuspension enhances efficacy through altered pharmacokinetics in the rat. Int J Pharm 2007; 339: 251–60
   PubMed Web of Science ®Google Scholar
• Sant S, Thommes M, Hildgen P. Microporous structure and drug release kinetics of polymeric nanoparticles. Langmuir 2008; 24: 280–7
   PubMed Web of Science ®Google Scholar
• Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE. Biodegradable polymeric nanoparticles as drug delivery devices. J Control Release 2001; 70: 1–20
   PubMed Web of Science ®Google Scholar
• Steinbach WJ, Stevens DA. Review of newer antifungal and immunomodulatory strategies for invasive aspergillosis. Clin Infect Dis 2003; 37: S157–87
   PubMed Web of Science ®Google Scholar
• Walsh TJ, Pizzo A. Treatment of systemic fungal infections: Recent progress and current problems. Eur J Clin Microbiol Infect Dis 1988; 7: 460–75
   PubMed Web of Science ®Google Scholar
• Walsh TJ, Teppler H, Donowitz GR, Maertens JA, Baden LR, Dmoszynska A, Cornely OA, Bourque MR, Lupinacci RJ, Sable CA, et al. Caspofungin versus liposomal Amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia. N Engl J Med 2004; 351: 1391–402
   PubMed Web of Science ®Google Scholar
• Willems L, van der Geest R, De Beule K. Itraconazole oral solution and intravenous formulations: A review of pharmacokinetics and pharmacodynamics. J Clin Pharm Ther 2001; 26: 159–69
   PubMed Web of Science ®Google Scholar
• Yang A, Yang L, Liu W, Li Z, Xu H, Yang X. Tumor necrosis factor alpha blocking peptide loaded PEG–PLGA nanoparticles: Preparation and in vitro evaluation. Int J Pharm 2007; 331: 123–32
   PubMed Web of Science ®Google Scholar
• Yi Y, Yoon HJ, Kim BO, Shim M, Kim S-O, Hwang S-J, Seo MH. A mixed polymeric micellar formulation of itraconazole: Characteristics, toxicity and pharmacokinetics. J Control Release 2007; 117: 59–67
   PubMed Web of Science ®Google Scholar
• Yu BG, Okano T, Kataoka K, Sardari S, Kwon GS. In vitro dissociation of antifungal efficacy and toxicity for amphotericin B-loaded poly(ethylene oxide)-block-poly(β-benzyl-L-aspartate) micelles. J Control Release 1998; 56: 285–91
   PubMed Web of Science ®Google Scholar
• Zambaux MF, Bonneaux F, Gref R, Maincent P, Dellacherie E, Alonso MJ, Labrude P, Vigneron C. Influence of experimental parameters on the characteristics of poly(lactic acid) nanoparticles prepared by a double emulsion method. J Control Release 1998; 50: 31–40
   PubMed Web of Science ®Google Scholar
• Zhang L, Hu Y, Jiang X, Yang C, Lu W, Yang YH. Camptothecin derivative-loaded poly(caprolactone-co-lactide)-b-PEG-b-poly(caprolactone-co-lactide) nanoparticles and their biodistribution in mice. J Control Release 2004; 96: 135–48
   PubMed Web of Science ®Google Scholar
• Zhang L, Pornpattananangkul D, Hu CMJ, Huang CM. Development of nanoparticles for antimicrobial drug delivery. Curr Med Chem 2010; 17: 585–94
   PubMed Web of Science ®Google Scholar
• Zhao Q, Zhou H, Pesco-Koplowitz L. Pharmacokinetics of intravenous itraconazole followed by itraconazole oral solution in patients with human immunodeficiency virus infection. J Clin Pharmacol 2001; 41: 1319–28
   PubMed Web of Science ®Google Scholar